---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-006511"
form_type: "8-K"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2023-09-18T23:59:59+00:00"
generated_at: "2026-06-10T15:42:26.783938+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aethlon Medical stockholders approve reverse stock split of 1:8 to 1:12

## Summary
- Reverse stock split approved by 6,781,311 for, 2,180,424 against; Board to set ratio and effective date by Oct 5, 2023.
- All six director nominees elected: Broenniman, Cipriani, Fisher, Gikakis, Rossetti, Shah.
- Baker Tilly US ratified as independent auditor for fiscal 2024 with 8,177,582 for, 562,051 against.
- Voter turnout 36.29% (9,012,954 of 24,835,321 shares present).

## SEC filing metadata
- accession: 0001683168-23-006511
- form_type: 8-K
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2023-09-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316823006511/0001683168-23-006511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316823006511/aethlon_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-006511
- JSON: https://secwatch.observer/filing/0001683168-23-006511.json
- Plain text: https://secwatch.observer/filing/0001683168-23-006511.txt

## Key facts
- Shareholder Votes
  AETHLON MEDICAL INC shareholders approved Approve, pursuant to Nevada Revised Statutes (“NRS”) 78.2055, a reverse stock split of our common stock at a ratio in the range of 1-for-8 to 1-for-12, with such ratio to be determined in the discretion of the Board and with such reverse stock split to be effected at such time and date as determined at the 2023-09-15 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-09-15
  source text: Approve, pursuant to Nevada Revised Statutes (“NRS”) 78.2055, a reverse stock split of our common stock at a ratio in the range of 1-for-8 to 1-for-12, with such ratio to be determined in the discretion of the Board and with such reverse stock split to be effected at such time and date as determined by the Board in its sole discretion (but in no event later than October 5, 2023). The resolution was approved. Votes For Votes Against Abstentions 6,781,311 2,180,424 51,219
  evidence_url: https://www.sec.gov/Archives/edgar/data/882291/000168316823006511/0001683168-23-006511-index.htm
- Shareholder Votes
  AETHLON MEDICAL INC shareholders approved Elect six members of our Board of Directors at the 2023-09-15 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-09-15
  source text: Elect six members of our Board of Directors (the “Board”). All of the nominees were elected. Name Votes For Votes Against Abstentions Edward G. Broenniman 4,746,036 435,339 120,979 Guy F. Cipriani 4,859,449 322,920 119,985 Charles J. Fisher, Jr., MD 4,857,852 328,276 116,226 Nicolas Gikakis 4,859,443 321,710 121,201 Angela Rossetti 4,855,281 327,149 119,924 Chetan S. Shah, MD 4,870,838 316,233 115,283
  evidence_url: https://www.sec.gov/Archives/edgar/data/882291/000168316823006511/0001683168-23-006511-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.